Employment Verification
for Turning Point Therapeutics.
Fast, secure, and automated employment verification for Turning Point Therapeutics employees.
$39.99 per verification
Pay only when it worksAbout Turning Point Therapeutics
Turning Point Therapeutics was a clinical-stage precision oncology pharmaceutical company founded in 2013 and headquartered in San Diego, California. The company focused on developing novel small molecule therapies that address treatment resistance in cancer patients. Their lead drug candidate, repotrectinib, was designed to target ROS1+ advanced non-small cell lung cancer and NTRK+ advanced solid tumors. The company went public through an initial public offering (IPO) on NASDAQ in April 2019, trading under the ticker symbol TPTX. Their research and development efforts centered on their proprietary macrocycle platform, which was designed to create compact drug compounds that could effectively target specific genetic mutations driving cancer growth. In August 2022, Bristol Myers Squibb acquired Turning Point Therapeutics for approximately $4.1 billion ($76.00 per share). The acquisition aimed to enhance Bristol Myers Squibb’s oncology portfolio, particularly in precision medicine. At the time of acquisition, Turning Point had multiple clinical-stage drug candidates in development, including TPX-0131 for ALK-positive non-small cell lung cancer and TPX-0046 for RET-positive cancers. The company’s scientific approach focused on developing next-generation tyrosine kinase inhibitors (TKIs) that could overcome treatment resistance mechanisms in cancer therapy.
The information on this page is not an endorsement of Truv’s services by Turning Point Therapeutics and is meant to be purely informational.
Verify Turning Point Therapeutics Employees
- Fast and automated verification: Most employment and income verifications are completed in under 24 hours.
- Secure and reliable: Truv is SOC2 TYPEII Compliant. Certified for Fannie Mae’s Day 1 Certainty® and Freddie Mac’s AIM®.
- Cost-effective pricing: Pay only for successful verifications and save up to 50% compared to competitors.
Category
BiotechnologyNumber of employees
200.0 – 500.0
Information sourced from public company data.
Turning Point Therapeutics Employment Verification FAQs.
You can verify employment for Turning Point Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Turning Point Therapeutics and many other employers.
Yes, Truv offers both employment and income verification services for Turning Point Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include BioNTech, Talis Biomedical and Homology Medicines.
No, the information provided about Truv’s verification services is not an endorsement by the Turning Point Therapeutics.
Not the employer you were looking for?
Also verified with Truv
About Turning Point Therapeutics
Turning Point Therapeutics was a clinical-stage precision oncology pharmaceutical company founded in 2013 and headquartered in San Diego, California. The company focused on developing novel small molecule therapies that address treatment resistance in cancer patients. Their lead drug candidate, repotrectinib, was designed to target ROS1+ advanced non-small cell lung cancer and NTRK+ advanced solid tumors. The company went public through an initial public offering (IPO) on NASDAQ in April 2019, trading under the ticker symbol TPTX. Their research and development efforts centered on their proprietary macrocycle platform, which was designed to create compact drug compounds that could effectively target specific genetic mutations driving cancer growth. In August 2022, Bristol Myers Squibb acquired Turning Point Therapeutics for approximately $4.1 billion ($76.00 per share). The acquisition aimed to enhance Bristol Myers Squibb’s oncology portfolio, particularly in precision medicine. At the time of acquisition, Turning Point had multiple clinical-stage drug candidates in development, including TPX-0131 for ALK-positive non-small cell lung cancer and TPX-0046 for RET-positive cancers. The company’s scientific approach focused on developing next-generation tyrosine kinase inhibitors (TKIs) that could overcome treatment resistance mechanisms in cancer therapy.
The information on this page is not an endorsement of Truv’s services by Turning Point Therapeutics and is meant to be purely informational.
Verify Turning Point Therapeutics Employees
Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee. Learn more
Category
BiotechnologyNumber of employees
200.0 – 500.0
Turning Point Therapeutics Employment Verification FAQ.
You can verify employment for Turning Point Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Turning Point Therapeutics and many other employers.
Yes, Truv offers both employment and income verification services for Turning Point Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasizes security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include BioNTech, Talis Biomedical and Homology Medicines.
No, the information provided about Truv’s verification services is not an endorsement by the Turning Point Therapeutics.
Yes, Truv provides an option to « Start a verification » directly from this website for Turning Point Therapeutics employees and employees of many other organizations.